EQNR323.30-4.60%
MOWI187.80-1.57%
YARA432.10+0.30%
TEL144.40+1.69%
Brent$74.00-2.61%
USD/NOK9,8084−0,34 %
EUR/NOK11,2140−0,18 %
LIVE · 15:21 UTC
AVAI.PK56

Avai Bio Inc

Online ServicesLatest Reported

Avai Bio Inc has a highly leveraged capital structure, with total liabilities of $1.79 million and total equity of -$1.47 million, resulting in a debt-to-equity ratio of -0.48. The company's liquidity position is weak, as evidenced by a current ratio of 0.06 and only $280 in cash and equivalents. The negative free cash flow of -$256,160 and operating cash flow of -$1.32 million indicate significant cash outflows, which could constrain the company's ability to fund operations or reduce debt. The company's profitability is negative, with a net loss of $303,430 and an operating loss of $303,430. The return on equity of 20.69% is misleading due to the negative equity base, and the return on assets of -9.42% reflects poor asset utilization. These metrics fall well below the industry norms for a company in the online services sector, which typically requires strong revenue generation and efficient cost management. Avai Bio Inc does not report any revenue or segment data, and there is no geographic breakdown provided in the available data. The absence of revenue and segment details makes it difficult to assess the company's market reach or diversification. The company's operations are entirely in the online services sector, and there is no indication of geographic diversification. The company's growth trajectory is unclear due to the lack of historical revenue data and forward-looking guidance. The absence of revenue and the negative operating cash flow suggest that the company is not currently generating value for shareholders. The company's financial performance indicates a need for significant operational improvements or external funding to sustain operations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating potential challenges in meeting short-term obligations. The low dilution risk suggests that the company is not expected to issue additional shares in the near term, which is a positive sign for existing shareholders. There are no recent events or filings disclosed in the available data that would provide insight into the company's strategic direction or operational changes. The lack of recent activity or disclosures makes it difficult to assess the company's current status or future prospects.

30-day price · AVAI.PK-0.19 (-56.1%)
Low$0.14High$0.37Close$0.15As of25 Jun, 00:00 UTC
Profile
CompanyAvai Bio Inc
TickerAVAI.PK
SectorTechnology
BusinessSoftware & IT Services
Industry groupSoftware & IT Services
IndustryOnline Services
AI analysis

Business. Avai Bio Inc is a technology company operating in the software and IT services sector, specializing in online services.

Classification. Avai Bio Inc is classified under the Technology economic sector, Software & IT Services business sector, and Online Services industry with a confidence level of 0.92.

Avai Bio Inc has a highly leveraged capital structure, with total liabilities of $1.79 million and total equity of -$1.47 million, resulting in a debt-to-equity ratio of -0.48. The company's liquidity position is weak, as evidenced by a current ratio of 0.06 and only $280 in cash and equivalents. The negative free cash flow of -$256,160 and operating cash flow of -$1.32 million indicate significant cash outflows, which could constrain the company's ability to fund operations or reduce debt. The company's profitability is negative, with a net loss of $303,430 and an operating loss of $303,430. The return on equity of 20.69% is misleading due to the negative equity base, and the return on assets of -9.42% reflects poor asset utilization. These metrics fall well below the industry norms for a company in the online services sector, which typically requires strong revenue generation and efficient cost management. Avai Bio Inc does not report any revenue or segment data, and there is no geographic breakdown provided in the available data. The absence of revenue and segment details makes it difficult to assess the company's market reach or diversification. The company's operations are entirely in the online services sector, and there is no indication of geographic diversification. The company's growth trajectory is unclear due to the lack of historical revenue data and forward-looking guidance. The absence of revenue and the negative operating cash flow suggest that the company is not currently generating value for shareholders. The company's financial performance indicates a need for significant operational improvements or external funding to sustain operations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating potential challenges in meeting short-term obligations. The low dilution risk suggests that the company is not expected to issue additional shares in the near term, which is a positive sign for existing shareholders. There are no recent events or filings disclosed in the available data that would provide insight into the company's strategic direction or operational changes. The lack of recent activity or disclosures makes it difficult to assess the company's current status or future prospects.
Key takeaways
  • Avai Bio Inc has a highly leveraged capital structure with a debt-to-equity ratio of -0.48.
  • The company is experiencing significant cash outflows, with a negative free cash flow of -$256,160.
  • The company's profitability is negative, with a net loss of $303,430 and an operating loss of $303,430.
  • The company's liquidity position is weak, as evidenced by a current ratio of 0.06 and only $280 in cash and equivalents.
  • The company's growth trajectory is unclear due to the lack of historical revenue data and forward-looking guidance.
Financial snapshot
PeriodLatest reported
CurrencyUSD
Revenue$0.00
Gross profit$0.00
Operating income-$303.4k
Net income-$303.4k
R&D
SG&A
D&A
SBC
Operating cash flow-$1.3M
CapEx-$149.0k
Free cash flow-$256.2k
Total assets$322.0k
Total liabilities$1.8M
Total equity-$1.5M
Cash & equivalents$280.00
Long-term debt$706.8k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.2M-$303.7k-$302.3k-$206.3k
FY-3$921.3k-$343.1k-$126.5k$6.0k
FY-2$276.3k-$363.6k-$348.9k-$226.6k
FY-1$0.00-$2.1M-$2.1M-$2.0M
FY0$0.00-$1.5M-$1.1M-$1.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$816.3k-$327.4k$60.4k
FY-3$454.7k-$405.6k$33.3k
FY-2$241.5k-$633.3k$107.5k
FY-1$322.0k-$1.5M$280.00
FY0$224.8k-$1.6M$81.0k
PeriodOCFCapExFCFSBC
FY-4-$23.1k-$206.3k
FY-3-$535.0k$6.0k
FY-2-$54.5k-$33.5k-$226.6k
FY-1-$1.3M-$149.0k-$2.0M
FY0-$1.2M$0.00-$1.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$0.00-$303.4k-$303.4k-$256.2k
FQ-6$0.00-$517.3k-$528.8k-$290.4k
FQ-5$0.00-$623.0k-$623.0k-$606.3k
FQ-4$0.00-$428.9k-$452.3k-$435.6k
FQ-3$0.00$38.5k$464.1k$479.8k
FQ-2$0.00-$487.6k-$487.6k-$481.1k
FQ-1$0.00-$394.7k-$453.0k-$446.5k
FQ0$0.00-$509.8k-$553.7k-$547.2k
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$322.0k-$1.5M$280.00
FQ-6$244.9k-$2.1M$440.00
FQ-5$181.0k-$1.8M$1.8k
FQ-4$174.9k-$2.1M$3.1k
FQ-3$224.8k-$1.6M$81.0k
FQ-2$145.3k-$2.0M$10.1k
FQ-1$231.4k-$2.3M$92.0k
FQ0$172.9k-$2.8M$50.4k
PeriodOCFCapExFCFSBC
FQ-7-$1.3M-$149.0k-$256.2k
FQ-6-$12.7k-$290.4k
FQ-5-$838.8k$0.00-$606.3k
FQ-4-$973.1k$0.00-$435.6k
FQ-3-$1.2M$0.00$479.8k
FQ-2-$240.3k-$481.1k
FQ-1-$611.9k-$446.5k
FQ0-$959.0k-$547.2k
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$1.5M
Net cash-$706.5k
Current ratio0.1
Debt/Equity-0.5
ROA-94.2%
ROE20.7%
Cash conversion4.4%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Online Services · cohort 366 companies
MetricAVAI.PKActivity
Op margin3.7% medp25 -8.2% · p75 13.4%
Net margin2.9% medp25 -8.2% · p75 11.0%
Gross margin50.7% medp25 32.2% · p75 71.5%
CapEx / revenue-2.1% medp25 -5.4% · p75 -0.6%
Debt / equity-48.0%12.3% medp25 0.7% · p75 42.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:26 UTC#ba2ce357
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 10:30 UTCJob: 60e9b329